• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM TOXOPLASMA IGM (TOXO M); TOXOPLASMA GONDII IMMUNOGLOBULIN M IMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM TOXOPLASMA IGM (TOXO M); TOXOPLASMA GONDII IMMUNOGLOBULIN M IMMUNOASSAY Back to Search Results
Model Number 10995701
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/08/2023
Event Type  malfunction  
Manufacturer Narrative
A customer from outside the united states reported observation of a false negative atellica im toxoplasma igm (toxo m) result which was discordant relative to repeat testing of the same sample.Following observation of the identified discordant negative result among a series of positive results, the instrument in question was subjected to service, including acid-pump replacement (preventive maintenance), and successful checks of washing station, acid priming, and system start-up.Quality control (qc) results were as expected, and no issues were observed with later routine testing.There are no known reports of patient intervention or adverse health consequences due to the apparent false negative toxo m result.The atellica im toxoplasma igm (toxo m) instructions for use (ifu) states the following, under interpretation of results: "results of this assay should always be interpreted in conjunction with the patient's medical history, clinical presentation, and other findings." siemens healthcare diagnostics is investigating.
 
Event Description
A customer reported observation of a negative atellica im toxoplasma igm (toxo m) result which was discordant relative to repeat testing.An initial positive toxoplasma igm (toxo m) result was obtained.The same sample was repeat-tested on an alternate atellica im 1600 analyzer, which produced a negative result.The same sample was again repeated on the initial analyzer and produced a positive result.The same sample was then repeated on the second analyzer, returning a positive result.The positive result was considered correct and reported to the physician.There are no known reports of patient intervention or adverse health consequences due to the apparent false negative toxo m result.
 
Manufacturer Narrative
Mdr 2432235-2023-00150 was initially submitted 2023-06-13.Update, 2023-07-25: siemens has concluded the investigation.A customer from outside the united states reported observation of a false negative atellica im toxoplasma igm (toxo m) result which was discordant relative to repeat testing of the same sample.Following observation of the identified discordant negative result among a series of positive results, the instrument in question was subjected to service, which included minor parts replacement and a number of adjustments and interventions.Assay calibration and quality control (qc) results were reported to be within acceptable ranges, but data were not provided for review.Siemens reviewed internal assay data, and determined that toxo m lot 398 met all applicable release criteria, and was comparable to other reagent lots.Additional information was requested multiple times, but not provided.The customer¿s effective assay sensitivity cannot be estimated.Siemens reviewed field patient data and determined that result distributions for kit lot 398 were comparable to those of other lots.The identified non-reproducible result appears to be an isolated event.No product issue has been identified, and the local issue was resolved by routine service intervention.The customer is operational, and no additional action is required.Note: in section h6, the codes for investigation findings and investigation conclusion have been updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA IM TOXOPLASMA IGM (TOXO M)
Type of Device
TOXOPLASMA GONDII IMMUNOGLOBULIN M IMMUNOASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC
333 coney street
east walpole MA 02032
Manufacturer Contact
barry memishian
511 benedict ave.
tarrytown, NY 10591
5082985306
MDR Report Key17116947
MDR Text Key318078541
Report Number2432235-2023-00150
Device Sequence Number1
Product Code LGD
UDI-Device Identifier00630414600147
UDI-Public00630414600147
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K010755
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 08/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/13/2023
Device Model Number10995701
Device Catalogue Number10995701
Device Lot Number398
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/08/2023
Initial Date FDA Received06/13/2023
Supplement Dates Manufacturer Received07/25/2023
Supplement Dates FDA Received08/01/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/13/2023
Is the Device Single Use? No
Type of Device Usage Initial
Patient Sequence Number1
-
-